Publication number: 20210285967
Abstract: The invention relates to an in vitro or ex vivo method for differentially diagnosing a bipolar disorder and a major depressive disorder in a human patient in a need thereof presenting depressive symptoms, comprising the following steps: providing a biological sample from said patient; determining, from said biological sample, the abundance of at least one of the following cytokines TNF-?, IFN-?, IL-6, IL-10, IL-12p40, IL-15, IL-16, IL-17A and IL-27; and diagnosing a bipolar disorder or a major depressive disorder from the determination of the abundance of the at least one of the following cytokines TNF-?, IFN-?, IL-6, IL-10, IL-12p40, IL-15, IL-16, IL-17A and IL-27.
Type:
Application
Filed:
October 4, 2019
Publication date:
September 16, 2021
Applicants:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, UNIVERSITÉ D'AIX-MARSEILLE (AMU), UNIVERSITÉ CÔTE D'AZUR, ASSISTANCE PUBLIQUE - HÔPITAUX DE MARSEILLE (AP-HM), SORBONNE UNIVERSITE, UNIVERSITE DE MONTPELLIER, CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER
Inventors:
Wafa Bel Haj Ali, El Chérif Ibrahim, Raoul Belzeaux, Lionel Fillatre, Nicolas Glaichenhaus, Philippe Courtet, Emanuela Martinuzzi, Susana Do Carmo Pinto Barbosa